Elevated Matrix Metalloproteinase Concentrations Offer Novel Insight Into Their Role in Pediatric Tuberculous Meningitis
Author(s) -
Yifan Joshua Li,
Katalin A. Wilkinson,
Robert J. Wilkinson,
Anthony Figaji,
Ursula K. Rohlwink
Publication year - 2019
Publication title -
journal of the pediatric infectious diseases society
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.269
H-Index - 31
eISSN - 2048-7207
pISSN - 2048-7193
DOI - 10.1093/jpids/piy141
Subject(s) - medicine , tuberculous meningitis , cerebrospinal fluid , gelatinases , matrix metalloproteinase , meningitis , matrix metalloproteinase 9 , lumbar puncture , metalloproteinase , lumbar , pathology , tissue inhibitor of metalloproteinase , csf albumin , gelatinase , surgery
We collected lumbar and ventricular cerebrospinal fluid and serum from 40 children treated for tuberculous meningitis and measured the concentrations of gelatinases and their inhibitors. The concentrations of matrix metalloproteinase 9 (MMP-9), MMP-2, tissue inhibitor of metalloproteinase 1 (TIMP-1), and TIMP-2 were significantly elevated in the lumbar CSF samples, and we found interesting dynamics for MMP-9 that offer novel insight into its role in pediatric patients with tuberculous meningitis.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom